PharmaLink | Closing the Gap on Cradle-to-Grave Traceability via Reverse Distribution and EPCIS
PharmaLink | Closing the Gap on Cradle-to-Grave Traceability via Reverse Distribution and EPCIS
2 PagesCase Study: PharmaLink | Closing the Gap on Cradle-to-Grave Traceability via Reverse Distribution and EPCIS OCTOBER 28, 2019 Non-saleable pharmaceuticals—including returns, recalls, and other waste products—can leave a gap in supply chain security. But pharmaceutical returns specialist PharmaLink has found a solution this problem. Read PharmaLink’s case study poster and watch their FutureLink Nashville video to learn how the company’s combination of decommissioning and secure disposal is raising supply chain security levelsThe video features PharmaLink's Adam Q. Bottie, who recently took part in TraceLink's Digital Recalls FDA pilot. © 2020 TraceLink. All rights reserved. View Poster Session Gallery
